Clinical Trial: AU409 for the Treatment of Advanced Primary Liver Cancers or Solid Tumor With Liver Metastatic Disease
Study Status: Completed
Recruit Status: RECRUITING
Condition: Advanced Cholangiocarcinoma
Study Type: INTERVENTIONAL
Official Title: First in Human Dose Escalation Study of AU409 in Patients With Advanced Primary Liver Cancers or Advanced Solid Tumor With Liver Predominant Metastatic Disease
Brief Summary:
This phase I trial tests the safety, side effects, and best dose of a new intervention, AU409, in treating patients with primary liver cancers that may have spread from where it first started to nearby tissue, lymph nodes, or distant parts of the body (advanced) or advanced solid tumors that have spread to the liver (liver metastatic disease).AU409 may stop cancer from growing and spreading.This trial may help researchers determine if AU409 is safe and effective in treating patients with liver cancers and solid…
Read more